Weld Capital Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-3,814
Closed -$1.21M – 475
2020
Q1
$1.21M Buy
+3,814
New +$1.16M 0.62% 31
2019
Q4
– Sell
-4,477
Closed -$1.04M – 618
2019
Q3
$1.04M Buy
+4,477
New +$1.04M 0.19% 155
2019
Q1
– Sell
-5,204
Closed -$1.57M – 653
2018
Q4
$1.57M Buy
+5,204
New +$1.66M 0.35% 49

Other funds holding BIIB

Weld Capital Management's BIIB Position: Q2 2020 in Review

Weld Capital Management sold out of Biogen (BIIB) in Q2 2020, closing a stake of 3,814 shares — an estimated $1.21M sold.

Weld Capital Management first reported a position in BIIB in Q4 2018 and held it in 3 quarters. The position peaked at $1.57M in Q4 2018. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

  • Weld Capital Management reported no remaining Biogen position as of Q2 2020 after selling out during the quarter.
  • Weld Capital Management sold 3,814 Biogen shares in Q2 2020, an estimated $1.21M.
  • Weld Capital Management first reported a position in Biogen in Q4 2018 and held it in 3 quarters.
  • Weld Capital Management's Biogen position peaked at $1.57M in Q4 2018.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on Weld Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.